ACUVAIL

This brand name is authorized in United States. It is also authorized in Canada, Singapore, Turkey.

Active ingredients

The drug ACUVAIL contains one active pharmaceutical ingredient (API):

1	Ketorolac UNII 4EVE5946BQ - KETOROLAC TROMETHAMINE
	Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.
	Read more about Ketorolac

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACUVAIL Ophthalmic solution	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC05	Ketorolac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02369362
SG	Health Sciences Authority	14259P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699490561294
US	FDA, National Drug Code	0023-3507